Navigation Links
High Demand for a child vaccine

High demand for a new vaccine against childhood pneumonia, meningitis and ear infections has led to a shortage around the country. Meanwhile, doctors are directing the supplies they do have to children// who run the highest risk of infection, such as those with sickle cell anemia, the AIDS virus or other diseases that undermine the immune system.

PREVNAR fights the bacterium streptococcus pneumoniae, the leading cause of pneumonia, meningitis and millions of ear infections every year in children. According to the Food and Drug Administration, children under 5 suffer 16,000 pneumococcal blood infections and 1,400 pneumococcal meningitis cases every year. And until Prevnar, there has been no way to prevent them. Prevnar was approved by the FDA two years ago. In June, a government advisory committee recommended that all children under 2 receive the vaccine.

Demand soared, far exceeding the expectations of Wyeth-Ayerst, said drug company spokesman Douglas Pet, who estimates that 90 percent of infants in the United States have now received the vaccine. According to Hegan pediatricians are being told to delay the booster shot that children usually receive when they are a year old.

Henceforth if we immunize your baby at 2, 4, and 6 months, that immunity will last certainly past a year. If we don't give the 12-month dose until 18 months or 24 months, the children are still well protected.


'"/>




Page: 1

Related medicine news :

1. Demand for universal flu vaccination
2. Mentally Demanding Jobs Found To Reduce The Risk Of Alzheimer’
3. Research Fraud By Doctor – Probe Demanded
4. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
5. Bird Flu Likely To Reduce World Energy Demand
6. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
7. Sex Health Clinics Unable To Meet Increasing Demand
8. Bird Flu Scare Does Not Reduce Demand For Chicken
9. Demand For Diet Drugs On The Rise
10. High Demand For Circumcision In AIDS-Hit Swaziland
11. High Demand For Protective Suit in Afghan: Culling Would Have To Wait

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High Demand for child vaccine

(Date:11/25/2009)...FRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQuality... Spare the Air Alert forThursday,Nov...ogsoranyothersolidfuel,bothindoorsandoutdoors. ,...ualitytomorrow,"saidJackBroadbent,executiveofficer...pectthehealthoftheirneighborsandfellowcommunitymem...
(Date:11/25/2009)... survivors of testicular cancer who were treated w...ide effects, including neurological side effects a...reated with chemotherapy, according to a new study...he National Cancer Institute . , Marianne Brydy,...iversity Hospital, in Bergen, Norway, and colleagu...
(Date:11/25/2009)...itous discovery that grew out of a collaboration b...ally offer hope to the nearly 10 million Americans..., Also known as hardening of the arteries, perip...atory problem in which narrowed arteries reduce bl... a red flag for vascular disease, heart attack and...
(Date:11/25/2009)...ollow-up period was too short to draw definite con...ov. 25 (HealthDay News) -- In diabetic patients wi...no difference in outcomes at one year whether pati...enting, British researchers report. , Bypass su... patients with coronary artery disease. However, l...
(Date:11/25/2009)... Evaluation and treatment clinics to... Woodstock (Vocus) November 25, 2009 -- Centegra H...cines and H1N1 vaccine shots at four Centegra Prim...hipment of vaccine has arrived. The clinics are at... McHenry and will be open as follows: ,  ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...1, 2009 AMERIGROUP Corporation (NYSE: AGP ) t...r the fourth quarter ended December 31, 2008, befo.... At 8:30 a.m. Eastern Time on the same day, AMER...domestic) or 706-679-7245 (international) approxim...
...n observance of National Children,s Dental Health ... Association (PDA) is sponsoring its annual poster...re eligible to participate in the contest. , , T...lic libraries. In addition to the student prize, t...
...ould detect virus that can lead to failure, , ... urine test that can detect a common cause of kidn...nosis and treatment of patients with polyomavirus ...ems for people with compromised immune systems. Pe...
...ticle pollution correlate with increases in life e...y News) -- A new study shows there is a direct rel...tants in the air people breathe and life expectanc... meter of air adds about seven months of life expe...
...thy infant feeding can help stem the staggering ri...tate University nursing professor who will use a $...r infant feeding program. , Mildred Horodynski of...ces, known as infant-centered feeding. , Her thre...
...Pharmaceuticals, Inc. (Nasdaq: AMLN ) will webca...urth quarter and full year 2008 on Tuesday, Januar... Bradbury, Amylin,s president and chief executive ...08. , , The call will be webcast live through A...
Other Medicine News:Health News:AMERIGROUP Corporation to Discuss Fourth Quarter Earnings on February 19 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Cleaner Air Equals Longer Life 2Health News:Cleaner Air Equals Longer Life 3Health News:MSU researcher receives $1.5 million grant for childhood obesity intervention study 2Health News:Amylin Pharmaceuticals to Webcast Year-End Results 2
(Date:11/24/2009)....24/PRNewswire-Asia/--ChindexInternational,Inc.,("...anproviderofWestern,healthcareproductsandservicesi...Companywillattendthe21stAnnualPiperJaffray,"Unplug...atthe,NewYorkPalaceHotel. , Managementiscurre...er1,2009,andholdone-on-onemeetingsthroughouttheday...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasdaq:...orticdisorders,announcedtodaythatithasfiledamotion...ingementlawsuitbroughtagainstitinOctober2009byCook...rtinIndianapolis,Indiana. ,, Endologixhasreques...tentandTrademarkOffice(USPTO)conductsproceedingsto...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3InterMune to Release Third Quarter Financial Results on November 5 14645 1InterMune to Release Third Quarter Financial Results on November 5 14645 2Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 1Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 2MedCath Corporation to Hold Conference Call on Fourth Quarter Results 5826 1MedCath Corporation to Hold Conference Call on Fourth Quarter Results 5826 2
...aluate Safety, Efficacy of Novel Cortisol ...ept. 26 DiObex, Inc., a privately held,biotechnol...tics to treat,metabolic diseases, announced today ...inical trial of DIO-902, a novel cortisol synthesi...e 2 diabetes mellitus (T2DM). The Phase 2b multin...
...ive Nasal Spray Dosage form is Patient Friendly ...ry Delivery -, BOTHELL, Wash., Sept. 26 Nastech,...nced today the start of a,Phase 2 clinical trial e...,Spray in approximately 20 patients with type 2 di... evaluating formulations of Insulin Nasal Spray,as...
Other Medicine Technology:DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 2DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 3Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 2Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 3
Fixed Core Straight Safety Wire Guides - Standard (PTFE coated)
Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
Fascial Incising Needles
Two-Part Trocar Needles - Standard
Medicine Products: